Overview
Abdiel Capital is a New York-based investment firm that makes concentrated, long-only bets on publicly traded companies. It looks for firms likely to gain market share over long horizons, preferring recurring revenue and leaders with a large personal stake in the stock. The firm builds portfolios of high-conviction ideas and values them by the long-term cash flows the entire business could generate if owned outright. Abdiel differentiates itself by emphasizing under-the-hood factors like product quality, corporate culture, and insider ownership, and by maintaining a concentrated portfolio with a multi-year time horizon to pursue absolute returns that beat the market.
Work here?Claim your company
Simplify's Take
What believers are saying
- Abdiel crossed 5% of Lindbergh on February 25, 2026, adding fresh European exposure.
- Appian still grew 18% in 2025 revenue and posted positive GAAP income.
- Abdiel keeps buying durable, recurring-revenue names like HCA, AFRM, and GLBE.
What critics are saying
- Q2 2026 13F showed only five holdings, signaling severe concentration and portfolio shrinkage.
- Abdiel cut Appian 1,075,738 shares on February 17, 2026 after shares dropped.
- If Colin Moran exits, Abdiel's culture and strategy collapse immediately.
What makes Abdiel Capital unique
- Colin Moran runs Abdiel with concentrated, long-term public equity bets since 2006.
- Abdiel prefers recurring revenue and founders with meaningful personal ownership.
- Ten largest holdings often exceed 75% of invested capital.
Help us improve and share your feedback! Did you find this helpful?